Matraz redondo de nitrógeno con llave de paso, 50 ml, 29/32, 1 unidad

Vortioxetine hydrobromide, 97.0%, 100g

(2E)-3-(2,4-dichlorophenyl)-1-(2,4-dimethylphenyl)prop-2-en-1-one, 95.0%, 2g

2-Amino-4-phenyl-6-(trifluoromethyl)pyrimidine, 98.0%, 1g

2-(2-Chloro-4-fluorophenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane, 98%, 250mg

tert-Butyl 3-(bromomethyl)azetidine-1-carboxylate, 95.0%, 100g

1-METHYL-1H-PYRAZOLO[3,4-B]PYRIDINE-3-CARBALDEHYDE, 95.0%, 5g

3-Chloro-4-methylpyridazine, 97.0%, 10g

6-Methoxy-1,5-naphthyridin-2(1H)-one, 97%, 5g

5-Fluoropyridine-3-carboxylic acid, 97.0%, 100g

N-Benzyl-p-toluenesulfonamide>98.0%(HPLC)(N)25g

N-Hydroxy-acetimidic acid ethyl ester, 97.0%, 25g

3-(3-Hydroxy-prop-1-ynyl)-benzoic acid methyl ester, 1g